Trump announces he’s nominating Dr. Erica Schwartz for CDC director

Washington — President Trump announced Thursday that he’s nominating Dr. Erica Schwartz to run the Centers for Disease Control and Prevention.   Schwartz served as Mr. Trump’s deputy Surgeon General during his first term and as a Coast Guard rear admiral. She received her medical degree from Brown University and also holds a law degree

House breaks with Trump, votes against ending deportation protections for Haitians

Washington — The House delivered rare pushback on President Trump’s immigration policies in a vote Thursday on a bill to stop the administration from ending temporary deportation protections for Haitian nationals living in the U.S.  Democratic Rep. Ayanna Pressley of Massachusetts spearheaded the effort to force a vote through a procedural tool known as a

“Arc de Trump” receives preliminary design approval from arts commission

A Trump-appointed commission tasked with reviewing public buildings in Washington, D.C., raised questions about but ultimately gave preliminary design approval to one of President Trump’s architectural priorities: a 250-foot stone arch that would tower above the Lincoln Memorial and Arlington National Cemetery.  The commissioners questioned project architect Nicolas Charbonneau about the arch’s structural footings, pedestrian

Federal judge blocks above-ground White House ballroom construction

A federal judge on Thursday said above-ground work on the White House East Wing must stop, but underground construction on a presidential bunker can continue.  U.S. District Judge Richard Leon, who in March temporarily blocked the Trump administration’s construction of a 90,000-square-foot ballroom to replace the White House’s East Wing, clarified his order Thursday after a federal appeals

Trump to sign executive order on psychedelic drug used abroad to treat PTSD

A psychedelic used in some countries to treat post-traumatic stress disorder is expected to get a closer examination from the federal government on its safety and effectiveness, sources told CBS News. The White House is drafting an executive order that would signal the Trump administration’s willingness to further U.S. research into a drug called ibogaine.